QIM
BIOC

Quantitative Investment Management’s Biocept, Inc. BIOC Stock Holding History

Quantitative Investment Management’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1
Closed -$68K – 734
2015
Q1 		$68K Buy
+1
New +$67.2K 0.01% 594

Other funds holding BIOC

KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCM
Sterneck Capital Management Kansas City, Missouri $233M AUM 21.98% 1-Year Est. Return

Quantitative Investment Management's BIOC Position: Q2 2015 in Review

Quantitative Investment Management sold out of Biocept, Inc. (BIOC) in Q2 2015, closing a stake of 1 share — an estimated $68K sold.

Quantitative Investment Management first reported a position in BIOC in Q1 2015 and held it in 1 quarter. The position peaked at $68K in Q1 2015. 12 funds tracked by Wall St. Rank hold BIOC as of Q2 2015.

  • Quantitative Investment Management reported no remaining Biocept, Inc. position as of Q2 2015 after selling out during the quarter.
  • Quantitative Investment Management sold 1 Biocept, Inc. share in Q2 2015, an estimated $68K.
  • Quantitative Investment Management first reported a position in Biocept, Inc. in Q1 2015 and held it in 1 quarter.
  • Quantitative Investment Management's Biocept, Inc. position peaked at $68K in Q1 2015.
  • 12 funds tracked by Wall St. Rank held Biocept, Inc. as of Q2 2015.

Based on Quantitative Investment Management's 13F filing for Q2 2015, filed 5 Aug 2015.